DE69311394T2 - Arzneimittel verzögerter Wirkstoffabgabe - Google Patents

Arzneimittel verzögerter Wirkstoffabgabe

Info

Publication number
DE69311394T2
DE69311394T2 DE69311394T DE69311394T DE69311394T2 DE 69311394 T2 DE69311394 T2 DE 69311394T2 DE 69311394 T DE69311394 T DE 69311394T DE 69311394 T DE69311394 T DE 69311394T DE 69311394 T2 DE69311394 T2 DE 69311394T2
Authority
DE
Germany
Prior art keywords
release
active ingredient
drug delivery
expected
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69311394T
Other languages
English (en)
Other versions
DE69311394D1 (de
Inventor
Trevor John Knott
Stewart Thomas Leslie
Sandra Therese Antoi Malkowska
Ronald Brown Dr Miller
Derek Allan Prater
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929203689A external-priority patent/GB9203689D0/en
Priority claimed from GB929209520A external-priority patent/GB9209520D0/en
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Application granted granted Critical
Publication of DE69311394D1 publication Critical patent/DE69311394D1/de
Publication of DE69311394T2 publication Critical patent/DE69311394T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
DE69311394T 1992-02-20 1993-02-17 Arzneimittel verzögerter Wirkstoffabgabe Expired - Lifetime DE69311394T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929203689A GB9203689D0 (en) 1992-02-20 1992-02-20 Pharmaceutical composition
GB929209520A GB9209520D0 (en) 1992-05-01 1992-05-01 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
DE69311394D1 DE69311394D1 (de) 1997-07-17
DE69311394T2 true DE69311394T2 (de) 1997-10-30

Family

ID=26300352

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69311394T Expired - Lifetime DE69311394T2 (de) 1992-02-20 1993-02-17 Arzneimittel verzögerter Wirkstoffabgabe

Country Status (5)

Country Link
EP (1) EP0557064B1 (de)
JP (1) JP3623805B2 (de)
AT (1) ATE154238T1 (de)
DE (1) DE69311394T2 (de)
GB (1) GB2264639B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4318577A1 (de) * 1993-06-04 1994-12-08 Merck Patent Gmbh Schmiermittelfreie, arzneimittelhaltige Tabletten
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
AU5066101A (en) * 2000-04-13 2001-10-30 Synthon B.V. Modified release formulations containing a hypnotic agent

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
FR2585246A1 (fr) * 1985-07-26 1987-01-30 Cortial Procede d'obtention de formes pharmaceutiques solides a liberation prolongee
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
IL81419A0 (en) * 1986-01-30 1987-08-31 Syntex Inc Long acting sustained release pharmaceutical compositions containing dihydropyridines and their preparation
SE457326B (sv) * 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
CA1323833C (en) * 1987-04-28 1993-11-02 Yatindra M. Joshi Pharmaceutical compositions in the form of beadlets and method
GB2209669B (en) * 1987-09-11 1992-02-12 Squibb & Sons Inc Pharmaceutical composition containing high drug load and method for preparing same
DE3929864A1 (de) * 1989-09-08 1991-03-14 Nordmark Arzneimittel Gmbh Verfahren zur herstellung von theophyllin-pellets
EP0418597A3 (en) * 1989-09-21 1991-11-27 American Cyanamid Company Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form
EP0452862B1 (de) * 1990-04-18 1995-07-19 Asahi Kasei Kogyo Kabushiki Kaisha Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung
GB2258810B (en) * 1991-08-12 1996-01-31 Euro Celtique Sa Pharmaceutical combination formulation of diltiazem and hydrochlorothiazide
US5273760A (en) * 1991-12-24 1993-12-28 Euroceltigue, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer

Also Published As

Publication number Publication date
GB2264639A (en) 1993-09-08
ATE154238T1 (de) 1997-06-15
EP0557064B1 (de) 1997-06-11
DE69311394D1 (de) 1997-07-17
JPH0624964A (ja) 1994-02-01
JP3623805B2 (ja) 2005-02-23
GB9303132D0 (en) 1993-03-31
EP0557064A1 (de) 1993-08-25
GB2264639B (en) 1996-05-22

Similar Documents

Publication Publication Date Title
DE69311395D1 (de) Sphäroidische Arzneimittelformulierung
CA2126611A1 (en) Opiod Formulations Having Extended Controlled Release
IL111519A0 (en) Sustained release tablets having an insoluble active ingredient therein and methods for the preparation thereof
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
CA2179540A1 (en) Accelerated release composition containing bromocriptine
YU26102A (sh) Nove farmaceutske smese antituberkuloznih lekova i postupak za njihovo dobijanje
KR870002832A (ko) 제약 조성물
WO2001078725A3 (en) Modified release formulations containing a hypnotic agent
PT923934E (pt) Formulacao de matriz de libertacao modificada de cefaclor e cefalexina
DE3872739D1 (de) Arzneimittel mit langsamer freisetzung.
NO306894B1 (no) Anvendelse av galanthamin for fremstilling av en farmasöytisk formulering for behandling av nikotinavhengighet
ATE202926T1 (de) Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung
CA2340898A1 (en) Compositions and methods for treating intracellular infections
WO2001013898A3 (en) Pharmaceutical formulations with different release times
DE69622739D1 (de) Pharmazeutische zubereitung mit schneller freisetzung
DE69311394D1 (de) Arzneimittel verzögerter Wirkstoffabgabe
UA40636C2 (uk) Фармацевтична композиція для одержання стабільного порошку, яка містить як активний компонент асоціацію ацетилсаліцилової кислоти та метоклопраміду, фармацевтичний препарат у формі порошку та спосіб одержання цього препарату
ZA9610714B (en) Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet
EP1072261A3 (de) Felbinac enthaltendes Pflaster
EP0443028A4 (de) Nicht einspritzbares karzinostatisches mittel zur vorbeugung der entzündung durch 5-fluoruracil und verfahren zur behandlung von krebs.
CA2120001A1 (en) Flavopereirine-based pharmaceutical composition and use thereof for treating hiv
WO2005065641A3 (en) Non-disintegrating oral solid composition of high dose of water soluble drugs
HK1029277A1 (en) Pharmaceutical coating composition and method of use.
CA2187153A1 (en) Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: MOSELPATENT TRIERPATENT, 54290 TRIER

8328 Change in the person/name/address of the agent

Representative=s name: PATENTANWAELTE SERWE & DR. WAGNER, 54290 TRIER

R071 Expiry of right

Ref document number: 557064

Country of ref document: EP